CLHC1
Clathrin heavy chain linker domain-containing protein 1
Also known as: C2orf63, CLHC1_HUMAN, FLJ31438
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NHS4
- Gene
- CLHC1
- Ensembl
- ENSG00000162994
- Chromosome
- 2
- Canonical length
- 586 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoli fibrillar center,Centrosome
OverviewNCBI Gene
No narrative summary is available for CLHC1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
586 residues, UniProt reviewed canonical sequence.
>Q8NHS4|CLHC1
1 MSVHQIRKHA VLPPIICRSD KEFLESVQRY IITETERLGC SEEGPADEYY IIYRNVFDKV
61 IEHITAYKSI LTSIKKEYDA FIETIKKDRR TTFCLHGKLK GLAAEPTALV YYRKRTIQLE
121 AKMRIIESNS SKIQSQIDHI KQCRAEYDTK EVKYCTFSKD PSKPIPGMTL QESMNLDALT
181 KYMKHLEDKY AEIKQAMLIK YVPAQRKADL DEEMIVLLKR RDVAENLNKK LQFCHQRLQI
241 ISQALSSWVK SDMSSPFQDF VEQIQKTKYL QGDQGIVEEL MEDDPRRAKE AEIMLHYIER
301 FNELISLGEY EKAACYAANS PRRILRNIGT MNTFKAVGKI RGKPLPLLLF FEALFITSHA
361 FPCPVDAALT LEGIKCGLSE KRLDLVTNWV TQERLTFSEE AGDVICDYGE QDTYNKAKCL
421 ALAQIVYSEC GLHKKAILCL CKQGQTHRVM EYIQQLKDFT TDDLLQLLMS CPQVELIQCL
481 TKELNEKQPS LSFGLAILHL FSADMKKVGI KLLQEINKGG IDAVESLMIN DSFCSIEKWQ
541 EVANICSQNG FDKLSNDITS ILRSQAAVTE ISEEDDAVNL MEHVFWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLHC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- testis: 14 nTPM
- retina: 7.1 nTPM
- pituitary gland: 6.7 nTPM
- parathyroid gland: 5.1 nTPM
- fallopian tube: 4.9 nTPM
- prostate: 4.9 nTPM
Single-cell type
- ependymal cells: 230 nCPM
- choroid plexus epithelial cells: 190 nCPM
- respiratory ciliated cells: 138 nCPM
- late primary spermatocytes: 85 nCPM
- lactotrophs: 83 nCPM
- fallopian tube ciliated cells: 73 nCPM
Immune cell
- eosinophil: 1.3 nTPM
- NK-cell: 0.9 nTPM
- plasmacytoid DC: 0.8 nTPM
- intermediate monocyte: 0.6 nTPM
- naive CD4 T-cell: 0.6 nTPM
- memory CD4 T-cell: 0.5 nTPM
Brain region
- choroid plexus: 31 nTPM
- cerebellum: 20 nTPM
- midbrain: 18 nTPM
- medulla oblongata: 17 nTPM
- white matter: 15 nTPM
- cerebral cortex: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CLHC1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 116 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Marked Hypotonia
- Waddling gait
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.36
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.95
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- Armadillo-type fold
- Translin-associated factor X-interacting protein 1, N-terminal
- Clathrin-H-link
- Translin-associated factor X-interacting N-terminus
- Clathrin, heavy chain, linker
- Clathrin heavy chain linker domain-containing protein 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLHC1 as an antibody target. Whether an autoantibody or antibody against CLHC1 could matter depends on whether native CLHC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLHC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CLHC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...